Search results
NHS introduces Pfizer’s tafamidis for ATTR-CM treatment
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe UK's National Health Service (NHS) has introduced Pfizer's tafamidis for transthyretin...
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 6 days agoStrengths highlight Pfizer's robust product portfolio and global market presence. Weaknesses underscore the challenges in revenue fluctuations and patent...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
The Motley Fool via AOL· 1 day agoMoreover, there's a wide variety of healthcare companies, making it an attractive sector for any...
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 10 hours agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 4 hours agoAfter hitting a two-year high in February, biotech stocks sloughed off in April but have started to...
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Benzinga· 2 days agoPfizer Inc PFE is looking to build on the success of its COVID-19 vaccine rollout by introducing a...
Microsoft, Amazon, Pfizer, and others are investing a record $16 billion in France
Quartz· 2 days agoMicrosoft, Amazon, Pfizer, and other corporations announced Monday that they are investing a record...
Pfizer whistleblower shares chilling video: ‘Tired of feeling like I have no hope…but I am NOT...
BizPac Review· 6 days agoA woman has come forward claiming to be a Pfizer whistleblower with a helluva story to tell about the pharmaceutical giant. In addition, she’s published an ominous video declaring ...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock | The Motley...
The Motley Fool· 3 days agoPfizer (PFE -0.21%) stock has struggled over the past year, losing around 28% of its value. Its...
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks via Yahoo Finance· 5 days agoPfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA...